BK:NYSEThe Bank of New York Mellon Corporation Analysis
Data as of 2026-09-04 - not real-time
$63.64
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Baker Hughes Company is bullish at $63.64, with short-term averages leading the long-term ones. It has gained 13.5% over the past 30 days. RSI sits at 57.0, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $60.87 up to resistance at $65.44.
Multiples put this in fair territory: 20.8 times earnings against the sector's 17.9. Consensus targets land 13.3% above where the shares trade now. Revenue is contracting at 2.4% on a 11.2% profit margin.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 29.4%, a beta of 0.67 and a maximum drawdown of 24.2%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Multiples put this in fair territory: 20.8 times earnings against the sector's 17.9. Consensus targets land 13.3% above where the shares trade now. Revenue is contracting at 2.4% on a 11.2% profit margin.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 29.4%, a beta of 0.67 and a maximum drawdown of 24.2%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 58.42
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 20.8 versus sector average of 17.9
- Trading above the 200-day average of 58.42
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 20.8 versus sector average of 17.9
- Analyst targets imply +13.3% versus the current price
- Revenue contracting at -2.4%
Key Metrics & Analysis
Financial Health
Revenue Growth-2.40%
Profit Margin11.17%
P/E Ratio20.8
ROE16.46%
ROA4.85%
Debt/Equity80.92
P/B Ratio3.2
Op. Cash Flow$4.4B
Free Cash Flow$4.4B
Industry P/E17.9
Technical Analysis
TrendBullish
RSI57.0
Support$60.87
Resistance$65.44
MA 20$63.39
MA 50$59.83
MA 200$58.42
MACDBearish
VolumeStable
Fear & Greed Index96.02
Valuation
Fair Value$56.93
Target Price$72.13
Upside/Downside13.34%
GradeFair
TypeBlend
Risk Assessment
Beta0.67
Volatility29.41%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.